Asia Pacific Therapeutic Vaccines Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

Historic Data: 2021-2022   |   Base Year: 2024   |   Forecast Period: 2024-2031

Report Coverage:
  • Product (Cancer Vaccine, Infectious Disease Vaccine, Others)
  • Technology (Allogenic Vaccine and Autologus Vaccine)
  • End User (Hospitals, Clinics, Others)

No. of Pages: 126
Report Code: BMIRE00032092
Category: Life Sciences
Asia Pacific Therapeutic Vaccines Market
Free Sample Buy Now

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia Pacific Therapeutic Vaccines Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Therapeutic Vaccines Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia Pacific Therapeutic Vaccines Market Regional Analysis

6.2 Asia Pacific Therapeutic Vaccines Market Revenue 2021-2031 (US$ Thousand)
6.3 Asia Pacific Therapeutic Vaccines Market Forecast Analysis

7. Asia Pacific Therapeutic Vaccines Market Analysis – by Product

7.1 Cancer Vaccine
  • 7.1.1 Overview
  • 7.1.2 Cancer Vaccine: Asia Pacific Therapeutic Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
7.2 Infectious Disease Vaccine
  • 7.2.1 Overview
  • 7.2.2 Infectious Disease Vaccine: Asia Pacific Therapeutic Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
7.3 Others
  • 7.3.1 Overview
  • 7.3.2 Others : Asia Pacific Therapeutic Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Thousand)

8. Asia Pacific Therapeutic Vaccines Market Analysis – by Technology

8.1 Allogenic Vaccine and Autologus Vaccine
  • 8.1.1 Overview
  • 8.1.2 Allogenic Vaccine and Autologus Vaccine: Asia Pacific Therapeutic Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Thousand)

9. Asia Pacific Therapeutic Vaccines Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Hospitals: Asia Pacific Therapeutic Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 Clinics: Asia Pacific Therapeutic Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
9.3 Others
  • 9.3.1 Overview
  • 9.3.2 Others : Asia Pacific Therapeutic Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Thousand)

10. Asia Pacific Therapeutic Vaccines Market – Asia Pacific Analysis

10.1 Overview

10.2 Asia Pacific
  • 10.2.1 Asia Pacific Therapeutic Vaccines Market Breakdown, by Key Country, 2024 and 2031 (%)
  • 10.2.1.1 Asia Pacific Therapeutic Vaccines Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 Australia: Asia Pacific Therapeutic Vaccines Market – Revenue and Forecast to 2031 (US$ Thousand)
    • 10.2.1.1.1 Australia: Asia Pacific Therapeutic Vaccines Market Breakdown, by Product
    • 10.2.1.1.2 Australia: Asia Pacific Therapeutic Vaccines Market Breakdown, by Technology
    • 10.2.1.1.3 Australia: Asia Pacific Therapeutic Vaccines Market Breakdown, by End User
  • 10.2.1.2 China: Asia Pacific Therapeutic Vaccines Market – Revenue and Forecast to 2031 (US$ Thousand)
    • 10.2.1.2.1 China: Asia Pacific Therapeutic Vaccines Market Breakdown, by Product
    • 10.2.1.2.2 China: Asia Pacific Therapeutic Vaccines Market Breakdown, by Technology
    • 10.2.1.2.3 China: Asia Pacific Therapeutic Vaccines Market Breakdown, by End User
  • 10.2.1.3 India: Asia Pacific Therapeutic Vaccines Market – Revenue and Forecast to 2031 (US$ Thousand)
    • 10.2.1.3.1 India: Asia Pacific Therapeutic Vaccines Market Breakdown, by Product
    • 10.2.1.3.2 India: Asia Pacific Therapeutic Vaccines Market Breakdown, by Technology
    • 10.2.1.3.3 India: Asia Pacific Therapeutic Vaccines Market Breakdown, by End User
  • 10.2.1.4 Japan: Asia Pacific Therapeutic Vaccines Market – Revenue and Forecast to 2031 (US$ Thousand)
    • 10.2.1.4.1 Japan: Asia Pacific Therapeutic Vaccines Market Breakdown, by Product
    • 10.2.1.4.2 Japan: Asia Pacific Therapeutic Vaccines Market Breakdown, by Technology
    • 10.2.1.4.3 Japan: Asia Pacific Therapeutic Vaccines Market Breakdown, by End User
  • 10.2.1.5 South Korea: Asia Pacific Therapeutic Vaccines Market – Revenue and Forecast to 2031 (US$ Thousand)
    • 10.2.1.5.1 South Korea: Asia Pacific Therapeutic Vaccines Market Breakdown, by Product
    • 10.2.1.5.2 South Korea: Asia Pacific Therapeutic Vaccines Market Breakdown, by Technology
    • 10.2.1.5.3 South Korea: Asia Pacific Therapeutic Vaccines Market Breakdown, by End User
  • 10.2.1.6 Rest of Asia Pacific: Asia Pacific Therapeutic Vaccines Market – Revenue and Forecast to 2031 (US$ Thousand)
    • 10.2.1.6.1 Rest of Asia Pacific: Asia Pacific Therapeutic Vaccines Market Breakdown, by Product
    • 10.2.1.6.2 Rest of Asia Pacific: Asia Pacific Therapeutic Vaccines Market Breakdown, by Technology
    • 10.2.1.6.3 Rest of Asia Pacific: Asia Pacific Therapeutic Vaccines Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Dendreon
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 BioNTech SE
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Serum Institute of India Pvt. Ltd
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Merck & Co Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Amgen Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 ISA Pharmaceuticals BV
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 INOVIO Pharmaceuticals Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Transgene SA
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 THERAVECTYS SA
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 CureVac SE
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Asia Pacific Therapeutic Vaccines Market

  • Dendreon
  • BioNTech SE
  • Serum Institute of India Pvt. Ltd
  • Merck & Co Inc
  • Amgen Inc
  • ISA Pharmaceuticals BV
  • INOVIO Pharmaceuticals Inc
  • Transgene SA
  • THERAVECTYS SA
  • CureVac SE

    • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)